270 related articles for article (PubMed ID: 25436340)
1. Effect of landiolol hydrochloride on tachyarrhythmia after esophagectomy.
Niwa Y; Koike M; Iwata N; Kobayashi D; Tanaka C; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
Hepatogastroenterology; 2014 Sep; 61(134):1546-51. PubMed ID: 25436340
[TBL] [Abstract][Full Text] [Related]
2. Effect of landiolol hydrochloride, an ultra-short-acting beta 1-selective blocker, on supraventricular tachycardia, atrial fibrillation and flutter after pulmonary resection.
Nakano T; Shimizu K; Kawashima O; Kamiyoshihara M; Nagashima T; Ibe T; Takeyoshi I
J Clin Pharm Ther; 2012 Aug; 37(4):431-5. PubMed ID: 22059486
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of landiolol, an ultra-short-acting β1-selective antagonist, for treatment of sepsis-related tachyarrhythmia (J-Land 3S): a multicentre, open-label, randomised controlled trial.
Kakihana Y; Nishida O; Taniguchi T; Okajima M; Morimatsu H; Ogura H; Yamada Y; Nagano T; Morishima E; Matsuda N;
Lancet Respir Med; 2020 Sep; 8(9):863-872. PubMed ID: 32243865
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of landiolol hydrochloride for prevention of atrial fibrillation after cardiac surgery in patients with left ventricular dysfunction: Prevention of Atrial Fibrillation After Cardiac Surgery With Landiolol Hydrochloride for Left Ventricular Dysfunction (PLATON) trial.
Sezai A; Osaka S; Yaoita H; Ishii Y; Arimoto M; Hata H; Shiono M
J Thorac Cardiovasc Surg; 2015 Oct; 150(4):957-64. PubMed ID: 26254752
[TBL] [Abstract][Full Text] [Related]
5. Effects of landiolol hydrochloride on intractable tachyarrhythmia after pediatric cardiac surgery.
Tokunaga C; Hiramatsu Y; Kanemoto S; Takahashi-Igari M; Abe M; Horigome H; Sakakibara Y
Ann Thorac Surg; 2013 May; 95(5):1685-8. PubMed ID: 23506630
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of landiolol hydrochloride for atrial fibrillation after open heart surgery.
Nishi H; Sakaguchi T; Miyagawa S; Yoshikawa Y; Fukushima S; Saito S; Ueno T; Kuratani T; Sawa Y
Heart Vessels; 2013 Jul; 28(4):490-6. PubMed ID: 22661097
[TBL] [Abstract][Full Text] [Related]
7. Evaluating the Therapeutic Efficacy and Safety of Landiolol Hydrochloride for Management of Arrhythmia in Critical Settings: Review of the Literature.
Matsuishi Y; Mathis BJ; Shimojo N; Kawano S; Inoue Y
Vasc Health Risk Manag; 2020; 16():111-123. PubMed ID: 32308404
[TBL] [Abstract][Full Text] [Related]
8. Landiolol in the treatment of the intraoperative supraventricular tachycardia: a multicenter, randomized, double-blind, placebo-controlled study.
Xiao J; He P; Zou Q; Zhao Y; Xue Z; Deng X; Li S; Guo Q; Tao G; Yang T; Lang Z; He J; Wang X
J Clin Anesth; 2015 Mar; 27(2):120-8. PubMed ID: 25434501
[TBL] [Abstract][Full Text] [Related]
9. The suppressive effects of landiolol administration on the occurrence of postoperative atrial fibrillation and tachycardia, and plasma IL-6 elevation in patients undergoing esophageal surgery: A randomized controlled clinical trial.
Horikoshi Y; Goyagi T; Kudo R; Kodama S; Horiguchi T; Nishikawa T
J Clin Anesth; 2017 May; 38():111-116. PubMed ID: 28372647
[TBL] [Abstract][Full Text] [Related]
10. Landiolol hydrochloride for early postoperative tachycardia after transthoracic esophagectomy.
Mori K; Yamada K; Fukuda T; Mitsui T; Kitamura T; Yamaguchi D; Ando J; Wada I; Nomura S; Shimizu N; Seto Y
Surg Today; 2014 May; 44(5):848-54. PubMed ID: 23674201
[TBL] [Abstract][Full Text] [Related]
11. Effect of landiolol hydrochloride after off-pump coronary artery bypass.
Maisawa K; Yamazaki K; Ishitoya H; Shimamura Y
Asian Cardiovasc Thorac Ann; 2013 Apr; 21(2):170-5. PubMed ID: 24532615
[TBL] [Abstract][Full Text] [Related]
12. Postoperative administration of landiolol hydrochloride for patients with supraventricular arrhythmia: the efficacy of sustained intravenous infusion at a low dose.
Wariishi S; Yamashita K; Nishimori H; Fukutomi T; Yamamoto M; Radhakrishnan G; Sasaguri S
Interact Cardiovasc Thorac Surg; 2009 Nov; 9(5):811-3. PubMed ID: 19666952
[TBL] [Abstract][Full Text] [Related]
13. Landiolol: A Review in Tachyarrhythmias.
Syed YY
Drugs; 2018 Mar; 78(3):377-388. PubMed ID: 29470800
[TBL] [Abstract][Full Text] [Related]
14. [Use of landiolol hydrochloride for the prevention of atrial fibrillation after lung resection].
Okita T; Uji M; Shinjo T; Morioka M; Kumano H; Ishimura N; Nishiwada M
Masui; 2008 Aug; 57(8):953-8. PubMed ID: 18709998
[TBL] [Abstract][Full Text] [Related]
15. Randomized clinical trial of landiolol hydrochloride for the prevention of atrial fibrillation and postoperative complications after oesophagectomy for cancer.
Ojima T; Nakamori M; Nakamura M; Katsuda M; Hayata K; Kato T; Kitadani J; Tabata H; Takeuchi A; Yamaue H
Br J Surg; 2017 Jul; 104(8):1003-1009. PubMed ID: 28444964
[TBL] [Abstract][Full Text] [Related]
16. [Clinical evaluation of landiolol hydrochloride, an ultra short-acting beta-blocker].
Tanaka S; Kikuchi C; Saito N; Kasuya S
Kyobu Geka; 2008 Dec; 61(13):1096-101. PubMed ID: 19068694
[TBL] [Abstract][Full Text] [Related]
17. Landiolol hydrochloride for prevention of atrial fibrillation after coronary artery bypass grafting: new evidence from the PASCAL trial.
Sezai A; Minami K; Nakai T; Hata M; Yoshitake I; Wakui S; Shiono M; Hirayama A
J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1478-87. PubMed ID: 21269646
[TBL] [Abstract][Full Text] [Related]
18. Urgent management of rapid heart rate in patients with atrial fibrillation/flutter and left ventricular dysfunction: comparison of the ultra-short-acting β1-selective blocker landiolol with digoxin (J-Land Study).
Nagai R; Kinugawa K; Inoue H; Atarashi H; Seino Y; Yamashita T; Shimizu W; Aiba T; Kitakaze M; Sakamoto A; Ikeda T; Imai Y; Daimon T; Fujino K; Nagano T; Okamura T; Hori M;
Circ J; 2013; 77(4):908-16. PubMed ID: 23502991
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Landiolol Compared to Amiodarone for the Management of Postoperative Atrial Fibrillation in Intensive Care Patients.
Shibata SC; Uchiyama A; Ohta N; Fujino Y
J Cardiothorac Vasc Anesth; 2016 Apr; 30(2):418-22. PubMed ID: 26703973
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of an ultrashort-acting β1-blocker on left ventricular dysfunction.
Ito N; Tashiro T; Morishige N; Nishimi M; Hayashida Y; Minematsu N; Kuwahara G; Sukehiro Y; Teratani H
Heart Surg Forum; 2012 Aug; 15(4):E189-94. PubMed ID: 22917822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
